SUHAYL JOSEPH NASR
- Type
- Physician · Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Psychiatry
- Where
- MICHIGAN CITY, IN
- NPI
- 1891883062
- Received
- $739,304 in 712 records, 2019 to 2025
- As principal investigator
- $49,053 of research payments to others in 86 records
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2024 | General payment | 52 | $63,558 |
| 2023 | General payment | 200 | $239,170 |
| 2022 | General payment | 150 | $148,808 |
| 2021 | General payment | 62 | $66,813 |
| 2020 | General payment | 60 | $54,252 |
| 2019 | General payment | 188 | $166,700 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 149 | $171,891 | 2020–2024 |
| ABBVIE INC. | 130 | $139,073 | 2021–2024 |
| Neurocrine BioSciences, Inc. | 118 | $123,671 | 2019–2023 |
| Allergan, Inc. | 115 | $97,293 | 2019–2021 |
| Alkermes, Inc. | 60 | $66,365 | 2021–2024 |
| Axsome Therapeutics, Inc. | 41 | $54,012 | 2022–2023 |
| Otsuka America Pharmaceutical, Inc. | 53 | $47,491 | 2019–2022 |
| Teva Pharmaceuticals USA, Inc. | 29 | $24,891 | 2019–2023 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $8,851 | 2019 |
| Janssen Pharmaceuticals, Inc | 6 | $4,711 | 2019 |
| Sunovion Pharmaceuticals Inc. | 2 | $1,050 | 2019–2020 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 296 | $615,922 |
| Consulting Fee | 26 | $69,237 |
| Travel and Lodging | 196 | $40,199 |
| Food and Beverage | 192 | $11,501 |
| Honoraria | 1 | $2,437 |
| Education | 1 | $6 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2024-07-08 | Alkermes, Inc. | $7,720 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | LYBALVI Drug, CNS | 2024 | |
| 2024-07-08 | Alkermes, Inc. | $120 | Travel and Lodging | In-kind items and services | LYBALVI Drug, CNS | 2024 | |
| 2024-06-26 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $3,780 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-06-26 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $630 | Travel and Lodging | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-06-26 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $17 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-06-22 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $57 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-06-22 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $34 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-06-22 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $19 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-06-22 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $10 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-06-22 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $10 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-06-21 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $4,860 | Consulting Fee | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-06-21 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $226 | Travel and Lodging | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-06-21 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $124 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-06-21 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $120 | Travel and Lodging | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-06-21 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $28 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-06-09 | Alkermes, Inc. | $536 | Travel and Lodging | In-kind items and services | LYBALVI Drug, CNS | 2024 | |
| 2024-06-08 | Alkermes, Inc. | $303 | Travel and Lodging | In-kind items and services | LYBALVI Drug, CNS | 2024 | |
| 2024-06-08 | Alkermes, Inc. | $69 | Food and Beverage | In-kind items and services | LYBALVI Drug, CNS | 2024 | |
| 2024-06-08 | Alkermes, Inc. | $46 | Food and Beverage | In-kind items and services | LYBALVI Drug, CNS | 2024 | |
| 2024-06-08 | Alkermes, Inc. | $29 | Food and Beverage | In-kind items and services | LYBALVI Drug, CNS | 2024 | |
| 2024-06-08 | Alkermes, Inc. | $23 | Food and Beverage | In-kind items and services | LYBALVI Drug, CNS | 2024 | |
| 2024-06-08 | Alkermes, Inc. | $23 | Food and Beverage | In-kind items and services | LYBALVI Drug, CNS | 2024 | |
| 2024-06-08 | Alkermes, Inc. | $17 | Food and Beverage | In-kind items and services | LYBALVI Drug, CNS | 2024 | |
| 2024-06-07 | Alkermes, Inc. | $121 | Food and Beverage | In-kind items and services | LYBALVI Drug, CNS | 2024 | |
| 2024-05-31 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $3,780 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-05-31 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $1,412 | Travel and Lodging | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-05-31 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $29 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-05-30 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $2,160 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-05-30 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $53 | Travel and Lodging | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-05-30 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $15 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-05-29 | ABBVIE INC. | $3,850 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-04-30 | ABBVIE INC. | $951 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-04-30 | ABBVIE INC. | $66 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-04-02 | ABBVIE INC. | $3,850 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-03-05 | ABBVIE INC. | $225 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-03-05 | ABBVIE INC. | $18 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-02-15 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $5,400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-02-15 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $1,250 | Travel and Lodging | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-02-15 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $81 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-02-07 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $3,780 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-02-07 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $163 | Travel and Lodging | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-02-07 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $20 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-02-06 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $4,320 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-02-06 | ABBVIE INC. | $3,850 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-02-06 | ABBVIE INC. | $3,850 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-02-06 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $1,620 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-02-06 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $1,522 | Travel and Lodging | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-02-06 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $138 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-01-25 | ABBVIE INC. | $1,128 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-01-25 | ABBVIE INC. | $23 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-01-18 | ABBVIE INC. | $1,047 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-01-18 | ABBVIE INC. | $18 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2023-12-19 | ABBVIE INC. | $3,850 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-12-18 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $4,320 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-12-18 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $38 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-12-12 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $4,320 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-12-12 | ABBVIE INC. | $3,850 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-12-12 | ABBVIE INC. | $2,750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-12-12 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $133 | Travel and Lodging | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-12-12 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $84 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-12-07 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $4,320 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-12-07 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $1,250 | Travel and Lodging | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-12-07 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $41 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-11-30 | ABBVIE INC. | $1,145 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-11-30 | ABBVIE INC. | $116 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-11-28 | Alkermes, Inc. | $54 | Food and Beverage | In-kind items and services | LYBALVI Drug, CNS | 2023 | |
| 2023-11-27 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $2,700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-11-27 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $100 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-11-22 | ABBVIE INC. | $964 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-11-22 | ABBVIE INC. | $710 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-11-22 | ABBVIE INC. | $385 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-11-22 | ABBVIE INC. | $120 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-11-22 | ABBVIE INC. | $111 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-11-22 | ABBVIE INC. | $98 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-11-22 | ABBVIE INC. | $66 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-11-22 | ABBVIE INC. | $18 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-11-15 | Alkermes, Inc. | $4,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | LYBALVI Drug, CNS | 2023 | |
| 2023-11-14 | Alkermes, Inc. | $140 | Travel and Lodging | In-kind items and services | LYBALVI Drug, CNS | 2023 | |
| 2023-11-08 | Axsome Therapeutics, Inc. | $4,063 | Consulting Fee | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2023 | |
| 2023-11-08 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $3,780 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-11-08 | Axsome Therapeutics, Inc. | $1,875 | Consulting Fee | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2023 | |
| 2023-11-08 | Axsome Therapeutics, Inc. | $879 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2023 | |
| 2023-11-08 | Axsome Therapeutics, Inc. | $581 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2023 | |
| 2023-11-08 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $85 | Travel and Lodging | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-11-08 | Axsome Therapeutics, Inc. | $49 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2023 | |
| 2023-11-08 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $11 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-11-07 | Alkermes, Inc. | $2,500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | LYBALVI Drug, CNS | 2023 | |
| 2023-10-24 | ABBVIE INC. | $3,850 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-10-24 | ABBVIE INC. | $2,750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-10-20 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $540 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-10-18 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $2,160 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-10-18 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $44 | Travel and Lodging | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-10-18 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $27 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-10-16 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $2,160 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-10-16 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $16 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-10-12 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $2,160 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-10-12 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $540 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-10-11 | ABBVIE INC. | $3,850 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-10-09 | ABBVIE INC. | $78 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-10-09 | ABBVIE INC. | $78 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-10-09 | ABBVIE INC. | $20 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-10-09 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-10-05 | Neurocrine BioSciences, Inc. | $3,400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | INGREZZA Drug, Neuropsychiatry | 2023 | |
| 2023-10-05 | Neurocrine BioSciences, Inc. | $157 | Travel and Lodging | Cash or cash equivalent | INGREZZA Drug, Neuropsychiatry | 2023 | |
| 2023-10-05 | Neurocrine BioSciences, Inc. | $133 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2023 | |
| 2023-09-28 | Alkermes, Inc. | $2,500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | LYBALVI Drug, CNS | 2023 | |
| 2023-09-27 | ABBVIE INC. | $163 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-09-27 | ABBVIE INC. | $83 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-09-26 | ABBVIE INC. | $3,850 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-09-14 | Axsome Therapeutics, Inc. | $3,125 | Consulting Fee | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2023 | |
| 2023-09-14 | Alkermes, Inc. | $150 | Travel and Lodging | In-kind items and services | LYBALVI Drug, CNS | 2023 | |
| 2023-09-13 | Neurocrine BioSciences, Inc. | $3,400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | INGREZZA Drug, Neuropsychiatry | 2023 | |
| 2023-09-08 | ABBVIE INC. | $533 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-09-08 | ABBVIE INC. | $121 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-09-08 | ABBVIE INC. | $111 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-09-08 | ABBVIE INC. | $66 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-09-08 | ABBVIE INC. | $54 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-09-05 | Axsome Therapeutics, Inc. | $3,125 | Consulting Fee | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2023 | |
| 2023-08-31 | Axsome Therapeutics, Inc. | $2,813 | Consulting Fee | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2023 | |
| 2023-08-29 | ABBVIE INC. | $3,850 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-08-29 | ABBVIE INC. | $2,750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-08-25 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $40 | Travel and Lodging | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-08-10 | ABBVIE INC. | $117 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-08-10 | ABBVIE INC. | $80 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-08-10 | ABBVIE INC. | $74 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-08-10 | ABBVIE INC. | $18 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-08-08 | Alkermes, Inc. | $3,300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | LYBALVI Drug, CNS | 2023 | |
| 2023-07-21 | Alkermes, Inc. | $195 | Travel and Lodging | In-kind items and services | LYBALVI Drug, CNS | 2023 | |
| 2023-07-21 | Alkermes, Inc. | $157 | Travel and Lodging | In-kind items and services | LYBALVI Drug, CNS | 2023 | |
| 2023-07-15 | Axsome Therapeutics, Inc. | $32 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2023 | |
| 2023-07-14 | Axsome Therapeutics, Inc. | $3,125 | Consulting Fee | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2023 | |
| 2023-07-14 | Axsome Therapeutics, Inc. | $159 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2023 | |
| 2023-07-13 | Axsome Therapeutics, Inc. | $3,125 | Consulting Fee | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2023 | |
| 2023-07-13 | Axsome Therapeutics, Inc. | $66 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2023 | |
| 2023-07-13 | Axsome Therapeutics, Inc. | $55 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2023 | |
| 2023-07-06 | Alkermes, Inc. | $3,300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | LYBALVI Drug, CNS | 2023 | |
| 2023-07-03 | ABBVIE INC. | $3,850 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-07-03 | ABBVIE INC. | $2,750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-06-27 | Alkermes, Inc. | $2,500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | LYBALVI Drug, CNS | 2023 | |
| 2023-06-27 | Alkermes, Inc. | $2,500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | LYBALVI Drug, CNS | 2023 | |
| 2023-06-27 | Alkermes, Inc. | $111 | Travel and Lodging | In-kind items and services | LYBALVI Drug, CNS | 2023 | |
| 2023-06-27 | Alkermes, Inc. | $52 | Travel and Lodging | In-kind items and services | LYBALVI Drug, CNS | 2023 | |
| 2023-06-21 | Axsome Therapeutics, Inc. | $4,063 | Consulting Fee | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2023 | |
| 2023-06-21 | ABBVIE INC. | $3,850 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-06-21 | ABBVIE INC. | $3,850 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-06-21 | Axsome Therapeutics, Inc. | $213 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2023 | |
| 2023-06-21 | Axsome Therapeutics, Inc. | $123 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2023 | |
| 2023-06-21 | Axsome Therapeutics, Inc. | $45 | Food and Beverage | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2023 | |
| 2023-06-20 | Axsome Therapeutics, Inc. | $3,125 | Consulting Fee | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2023 | |
| 2023-06-20 | Axsome Therapeutics, Inc. | $123 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2023 | |
| 2023-06-15 | ABBVIE INC. | $199 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-06-15 | ABBVIE INC. | $160 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-06-15 | ABBVIE INC. | $150 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-06-15 | ABBVIE INC. | $118 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-06-14 | Alkermes, Inc. | $7,100 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | LYBALVI Drug, CNS | 2023 | |
| 2023-06-09 | Alkermes, Inc. | $125 | Travel and Lodging | In-kind items and services | LYBALVI Drug, CNS | 2023 | |
| 2023-06-09 | Alkermes, Inc. | $120 | Travel and Lodging | In-kind items and services | LYBALVI Drug, CNS | 2023 | |
| 2023-06-06 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $4,320 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-06-06 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $80 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-06-05 | Alkermes, Inc. | $21 | Food and Beverage | In-kind items and services | LYBALVI Drug, CNS | 2023 | |
| 2023-06-04 | ABBVIE INC. | $173 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-06-04 | ABBVIE INC. | $121 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-06-04 | ABBVIE INC. | $75 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-06-04 | ABBVIE INC. | $40 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-06-04 | ABBVIE INC. | $33 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-06-01 | ABBVIE INC. | $217 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-06-01 | ABBVIE INC. | $153 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-06-01 | ABBVIE INC. | $124 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-05-24 | Axsome Therapeutics, Inc. | $3,125 | Consulting Fee | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2023 | |
| 2023-05-24 | Axsome Therapeutics, Inc. | $157 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2023 | |
| 2023-05-23 | ABBVIE INC. | $825 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-05-18 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $3,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-05-18 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $118 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-05-17 | Axsome Therapeutics, Inc. | $3,125 | Consulting Fee | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2023 | |
| 2023-05-17 | Axsome Therapeutics, Inc. | $145 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2023 | |
| 2023-05-16 | ABBVIE INC. | $825 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-05-13 | Alkermes, Inc. | $272 | Travel and Lodging | In-kind items and services | LYBALVI Drug, CNS | 2023 | |
| 2023-05-13 | Alkermes, Inc. | $200 | Food and Beverage (4 payments) | In-kind items and services | LYBALVI Drug, CNS | 2023 | |
| 2023-05-12 | Alkermes, Inc. | $158 | Travel and Lodging | In-kind items and services | LYBALVI Drug, CNS | 2023 | |
| 2023-05-05 | Teva Pharmaceuticals USA, Inc. | $3,270 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | UZEDY Drug, Neurology | 2023 | |
| 2023-05-05 | Teva Pharmaceuticals USA, Inc. | $177 | Travel and Lodging | Cash or cash equivalent | UZEDY Drug, Neurology | 2023 | |
| 2023-05-03 | Alkermes, Inc. | $3,300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | LYBALVI Drug, CNS | 2023 | |
| 2023-05-02 | ABBVIE INC. | $3,850 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-05-02 | ABBVIE INC. | $2,750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-04-27 | Axsome Therapeutics, Inc. | $1,875 | Consulting Fee | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2023 | |
| 2023-04-27 | Axsome Therapeutics, Inc. | $1,687 | Consulting Fee | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2023 | |
| 2023-04-27 | Axsome Therapeutics, Inc. | $327 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2023 | |
| 2023-04-27 | Axsome Therapeutics, Inc. | $157 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2023 | |
| 2023-04-27 | Axsome Therapeutics, Inc. | $75 | Food and Beverage | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2023 | |
| 2023-04-27 | Axsome Therapeutics, Inc. | $21 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2023 | |
| 2023-04-25 | Axsome Therapeutics, Inc. | $1,687 | Consulting Fee | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2023 | |
| 2023-04-25 | Alkermes, Inc. | $159 | Travel and Lodging | In-kind items and services | LYBALVI Drug, CNS | 2023 | |
| 2023-04-20 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $3,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-04-20 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $124 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-04-19 | ABBVIE INC. | $288 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-04-19 | ABBVIE INC. | $124 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-04-19 | ABBVIE INC. | $88 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-04-13 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $1,875 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-04-13 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $118 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-03-28 | Axsome Therapeutics, Inc. | $1,687 | Consulting Fee | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2023 |
The latest 200 records of 712.
Research payments naming this person as principal investigator
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Michigan City, IN, county LaPorte County, IN, state Indiana; placed by its city name.
| Measure | Place (city or town) Michigan City, IN | County LaPorte County, IN | State Indiana |
|---|---|---|---|
| Population B01003 | 31,814 | 111,917 | 6,851,073 |
| Population, 2020 census P1 | 32,075 | 112,417 | 6,785,528 |
| Median age B01002 | 38.8 | 41.1 | 38.1 |
| Under 18 B01001 | 20.4% | 21.2% | 23.3% |
| 65 and over B01001 | 18.8% | 19.4% | 16.8% |
| Households B11001 | 13,008 | 43,633 | 2,716,009 |
| Foreign born B05002 | 2.9% | 3.4% | 6.3% |
| Median household income B19013 | $53,089 | $71,055 | $71,957 |
| Median family income B19113 | $73,418 | $84,464 | $90,767 |
| Per capita income B19301 | $29,810 | $35,395 | $38,351 |
| Poverty rate B17001 | 19.7% | 13.6% | 12.3% |
| Unemployment rate B23025 | 9.1% | 4.8% | 4.3% |
| Civilian labor force B23025 | 13,890 | 51,008 | 3,472,016 |
| Mean commute (minutes) B08013 | 21.3 | 25.0 | 24.1 |
| Bachelor's degree or higher B15003 | 20.3% | 22.7% | 29.5% |
| Housing units B25001 | 15,312 | 50,038 | 2,976,568 |
| Owner-occupied B25003 | 58.8% | 74.7% | 70.6% |
| Renters B25003 | 41.2% | 25.3% | 29.4% |
| Median home value B25077 | $143,100 | $195,500 | $218,200 |
| Median gross rent B25064 | $967 | $976 | $1,062 |
| White, not Hispanic B03002 | 61.0% | 76.0% | 75.4% |
| Black B03002 | 23.8% | 10.3% | 9.1% |
| Hispanic or Latino B03002 | 8.9% | 7.6% | 8.6% |
| Asian B03002 | 0.7% | 0.6% | 2.6% |
| American Indian and Alaska Native B03002 | 0.1% | 0.1% | 0.1% |
Economy now FRED unemployment 3.4% in Sep 2026 (3.7% a year earlier); per capita personal income $66,455 in 2025, up 28% in five years (+3.2% after inflation); the state; Source: FRED, Federal Reserve Bank of St. Louis.
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Michigan City, IN.
Comments